Gulfport Energy Corporation Appoints Deborah G. Adams to its Board of Directors
Mar 21, 2018 20:03 pm UTC| Business
OKLAHOMA CITY, March 21, 2018 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport”) today announced that Deborah G. Adams has been appointed to Gulfport’s Board of Directors (the “Board”). Ms. Adams has also been...
Mar 21, 2018 20:02 pm UTC| Business
THE COLONY, Texas, March 21, 2018 -- Quest Resource Holding Corporation (NASDAQ:QRHC) ("Quest"), a national provider of corporate sustainability services, announced that it will release results for its Fourth Quarter...
NuCana Reports Financial Results for the Year Ended December 31, 2017
Mar 21, 2018 20:01 pm UTC| Business
EDINBURGH, United Kingdom, March 21, 2018 -- NuCana plc (NASDAQ:NCNA) announced financial results for the year ended December 31, 2017 and provided an update on its extensive clinical program with its transformative...
OSS Reports 2017 Results: Net Revenue up 46% to Record $27.5 Million, Provides Guidance for 2018
Mar 21, 2018 20:01 pm UTC| Business
ESCONDIDO, Calif., March 21, 2018 -- OSS (NASDAQ:OSS), a leading provider of high performance computing systems, reported results for the year ended December 31, 2017 and provided guidance for 2018 revenue growth. ...
Gaia Announces Launch of Public Offering of Class A Common Stock
Mar 21, 2018 20:01 pm UTC| Business
LOUISVILLE, Colo., March 21, 2018 -- Gaia, Inc. (NASDAQ:GAIA) (the “Company”), a conscious community and media company, today announced the launch of an underwritten registered public offering of shares of its Class A...
Five Below, Inc. Announces Fourth Quarter and Fiscal 2017 Financial Results
Mar 21, 2018 20:01 pm UTC| Business
Reports fourth quarter sales growth of 30% to $504.8 million; diluted EPS increase of 34% to $1.21 Reports fiscal 2017 sales growth of 28%; diluted EPS increase of 42% to $1.84 Provides first quarter and full year...
Mar 21, 2018 20:01 pm UTC| Business
CAMBRIDGE, Mass., March 21, 2018 -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its...